NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry dataFirst published 30/09/2020 Last updated 23/04/2024 EU PAS number: EUPAS37258StudyOngoing
University of Southern Denmark (SDU)Denmark First published: 01/02/2024Last updated 27/03/2024 InstitutionEducational Institution
Centre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI)Sweden First published: 24/03/2010Last updated 23/04/2024 InstitutionEducational InstitutionLaboratory/Research/Testing facilityNot-for-profitENCePP partner
Pharmacoepi center, University of Southern DenmarkDenmark First published: 22/04/2010Last updated 27/07/2023 InstitutionEducational InstitutionENCePP partner
Department of Chronic Diseases, Pharmacoepidemiologic Research Group, Norwegian Institute of Public Health (NIPH)Norway First published: 29/04/2010Last updated 06/05/2024 InstitutionLaboratory/Research/Testing facilityOtherENCePP partner